marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Moderna Balance Sheet 2011-2024 | MRNA
Annual Balance Sheet Moderna
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-2.31 B | -2.26 B | -6.2 B | -2.52 B | -104 M | -625 M | -119 M | -37.6 M | - | - | - | - | - |
Long Term Debt |
575 M | 912 M | 599 M | 97.4 M | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
25 M | 35 M | 46 M | 5.97 M | 3.58 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 271 M | 209 M | 268 M | 413 M | - | - | - | - | - |
Total Current Liabilities |
3.02 B | 4.92 B | 9.13 B | 4.39 B | 143 M | 223 M | - | - | - | - | - | - | - |
Total Liabilities |
4.57 B | 6.74 B | 10.5 B | 4.78 B | 415 M | 432 M | 459 M | 575 M | - | - | - | - | - |
Deferred Revenue |
568 M | 2.04 B | 6.25 B | 3.87 B | 63.3 M | 109 M | 96.7 M | 108 M | - | - | - | - | - |
Retained Earnings |
13.6 B | 18.3 B | 9.96 B | -2.24 B | -1.5 B | -1.01 B | -622 M | -366 M | - | - | - | - | - |
Total Assets |
18.4 B | 25.9 B | 24.7 B | 7.34 B | 1.59 B | 1.96 B | 1.08 B | 1.42 B | - | - | - | - | - |
Cash and Cash Equivalents |
2.91 B | 3.2 B | 6.85 B | 2.62 B | 236 M | 658 M | 148 M | - | - | - | - | - | - |
Book Value |
13.9 B | 19.1 B | 14.1 B | 2.56 B | 1.17 B | 1.53 B | 625 M | 842 M | - | - | - | - | - |
Total Shareholders Equity |
13.9 B | 19.1 B | 14.1 B | 2.56 B | 1.17 B | 1.53 B | -551 M | -335 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Moderna
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
625 M | 576 M | 575 M | 575 M | 575 M | 843 M | 831 M | 912 M | 922 M | - | 646 M | 599 M | 238 M | 328 M | 138 M | 110 M | 110 M | 110 M | 110 M | 38.7 M | 38.7 M | 38.7 M | 38.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
3.88 B | 3.97 B | 3.91 B | 4.57 B | 6 B | 4.94 B | 5.26 B | 6.74 B | 8.06 B | - | 10.5 B | 10.5 B | 10.8 B | 9.45 B | 8.86 B | 4.78 B | 4.78 B | 4.78 B | 4.78 B | 415 M | 415 M | 415 M | 415 M | 432 M | 432 M | 432 M | 432 M | 459 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
379 M | 702 M | 559 M | 568 M | 1.37 B | 1.04 B | 1.22 B | 2.04 B | 4 B | - | 5.6 B | 6.25 B | 7.98 B | 7.3 B | 7.53 B | 3.87 B | 3.87 B | 3.87 B | 3.87 B | 63.3 M | 63.3 M | 63.3 M | 63.3 M | 109 M | 109 M | 109 M | 109 M | 96.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
11.2 B | 11.2 B | 12.4 B | 13.6 B | 13.4 B | 17 B | 18.4 B | 18.3 B | 16.9 B | - | 13.6 B | 9.96 B | 5.09 B | 1.76 B | -1.02 B | -2.24 B | -2.24 B | -2.24 B | -2.24 B | -1.5 B | -1.5 B | -1.5 B | -1.5 B | -1.01 B | -1.01 B | -1.01 B | -1.01 B | -622 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
15.8 B | 15.7 B | 16.7 B | 18.4 B | 19.4 B | 21.9 B | 24.1 B | 25.9 B | 26.1 B | - | 27.6 B | 24.7 B | 20.9 B | 16.2 B | 12.7 B | 7.34 B | 7.34 B | 7.34 B | 7.34 B | 1.59 B | 1.59 B | 1.59 B | 1.59 B | 1.96 B | 1.96 B | 1.96 B | 1.96 B | 1.08 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
1.64 B | 2.48 B | 2.05 B | 2.91 B | 2.93 B | 3.8 B | 3.44 B | 3.2 B | 3.03 B | 2.87 B | 5.05 B | 6.85 B | 5.55 B | 5.6 B | 5.44 B | 2.62 B | 2.62 B | 2.62 B | 2.62 B | 236 M | 236 M | 236 M | 236 M | 658 M | 658 M | 658 M | 658 M | 135 M | - | - | - | 50.1 M | - | - | - | 159 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
11.9 B | 11.7 B | 12.8 B | 13.9 B | 13.5 B | 16.9 B | 18.9 B | 19.1 B | 18 B | - | 17.1 B | 14.1 B | 10.1 B | 6.7 B | 3.84 B | 2.56 B | 2.56 B | 2.56 B | 2.56 B | 1.17 B | 1.17 B | 1.17 B | 1.17 B | 1.53 B | 1.53 B | 1.53 B | 1.53 B | 625 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
11.9 B | 11.7 B | 12.8 B | 13.9 B | 13.5 B | 16.9 B | 18.9 B | 19.1 B | 18 B | 18 B | 17.1 B | 14.1 B | 10.1 B | 6.7 B | 3.84 B | 2.56 B | 2.56 B | 2.56 B | 2.56 B | 1.18 B | 1.17 B | 1.17 B | 1.17 B | 1.53 B | 1.53 B | 1.53 B | 1.53 B | -551 M | - | - | - | -335 M | - | - | - | -150 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency